NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1831484419 MD
Verify on CMS → Anuja Kriplani, MD
Medical Oncology Physician in Montvale, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 4,028 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
423
Medicare Part D claims · 93 beneficiaries · Medical Oncology Physician avg: 732
Generic prescribing
79%
generic claims · 21% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
89.6/100
▲ 6 pts above national avg 83.5 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Anuja Kriplani, MD reported a CMS MIPS final score of 89.6/100 - above the 83.5 national average - and filed 423 Medicare Part D claims in 2024.
- 89.6/100
- MIPS score · +6 vs avg
- 423
- Part D claims, 2024
- 79%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Anuja Kriplani, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1831484419), first enumerated 06/13/2011.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 423 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 89.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
3 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1831484419 · Medical Oncology Physician
NPI-10 · ENUM-MID · TAX-NARROW · MIPS-ABOVE · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1831484419
- ENUM-MID 2011
- TAX-NARROW 4,028
- MIPS-ABOVE 89.6/100
- RX-LIGHT 423
- BOOK-THIN 93 in New Jersey
- PHOTO-FINISH Ghassan Abou-Alfa, MD · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Kriplani · this …
Kriplani · this provider
89.6 MIPS pts
- Viswatej Avutu, …
Viswatej Avutu, M.D.
89.6 MIPS pts
- Ghassan Abou-Alf…
Ghassan Abou-Alfa, MD
89.6 MIPS pts
- Nour Abuhadra · …
Nour Abuhadra
89.6 MIPS pts
- Kathryn Arbour, …
Kathryn Arbour, M.D.
89.6 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Anuja Kriplani, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
90 ≥ 56th percentile 56% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Anuja Kriplani, MD sits
This provider among medical oncology physician peers
Across the 1,398 medical oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Anuja Kriplani, MD writes more Part D claims than 49% of them and scores higher on MIPS quality than 63% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one medical oncology physician peer from a representative sample of 60; the gold marker is Anuja Kriplani, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Anuja Kriplani, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 3 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Anuja Kriplani, MD?
High performer (top quartile)Primary specialty
Medical Oncology Physician
Medicare Part D claims
423 42% vs specialty avg
MIPS final score
89.6/100 6.1 pts vs avg
Specialty distribution in New Jersey
How Medical Oncology Physician compares to other specialties among New Jersey providers
Medicare quality performance, MIPS
Anuja Kriplani, MD's 2023 MIPS final score plotted against the Medical Oncology Physician national average
- MIPS Final Score
- 89.6/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1831484419 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 06/13/2011 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
89.6113
Final Score
Measured-score avg: 83.5
81.8956
Quality
Reporting: Group practice
Hospital and facility affiliations
Facilities where Anuja Kriplani, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Anuja Kriplani, MD is affiliated with 3 Medicare-billing facilities across 2 states.
Memorial Solid Tumor Group
New York, NY
Msk Bergen
Montvale, NJ
Msk Harrison
West Harrison, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
Anuja Kriplani, MD - brand share 21.0%
Medical Oncology Physician average
21% brand-name claims vs 79% generic, on 423 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
423
Total Claims
$796K
Total Drug Cost
93
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 497.933
- Total Day Supply
- 11,014
- Brand vs Generic
- 21% brand / 79% generic
- Brand Drug Cost
- $759K
- Generic Drug Cost
- $37K
- Opioid Claims
- 17 (4.0% rate)
- Antibiotic Claims
- 24
Patient Demographics
- Average Patient Age
- 74.4 years
- Avg HCC Risk Score
- 2.91
- Gender Split
- 33% female / 67% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Anuja Kriplani, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Levothyroxine Sodium
Levothyroxine Sodium
78 claims
- Dexamethasone
Dexamethasone
44 claims
- Ondansetron Hcl
Ondansetron Hcl
35 claims
- Bicalutamide 20
Bicalutamide
20 claims
- Eliquis 17
Eliquis
17 claims
- Betamethasone Dipr… 14
Betamethasone Dipropionate
14 claims
- Mirtazapine 13
Mirtazapine
13 claims
- Oxycodone Hcl 13
Oxycodone Hcl
13 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 78 |
| Dexamethasone | 44 |
| Ondansetron Hcl | 35 |
| Bicalutamide | 20 |
| Eliquis Apixaban | 17 |
| Betamethasone Dipropionate | 14 |
| Mirtazapine | 13 |
| Oxycodone Hcl | 13 |
| Retevmo Selpercatinib | 12 |
| Prednisone | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Anuja Kriplani, MD fits within the Medical Oncology Physician landscape nationally.
4,028
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
732
Avg Claims per Provider
Anuja Kriplani, MD's 423 claims are below the specialty average of 732.
Nationwide Medical Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Kriplani, both outside New Jersey so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (89.6 here).
Same NPPES enumeration year (2011)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Medical Oncology Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Kriplani.
One of 93 Medical Oncology Physician providers enrolled in New Jersey, 5 are shown here.
Dr. Peter Abdelmessieh
DO
Robbinsville, NJ
Dr. Prashasti Agrawal
MD
Middletown, NJ
Joseph Aisner
New Brunswick, NJ
Dr. Sunny Arora
MD
West Long Branch, NJ
Brooke Barber
Hammonton, NJ
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Anuja Kriplani, MD's specialty? ▼
Anuja Kriplani, MD specializes in Medical Oncology Physician and practices in Montvale, New Jersey. Credentials: MD.
How much does Anuja Kriplani, MD prescribe under Medicare Part D? ▼
In 2024, Anuja Kriplani, MD wrote 423 Medicare Part D claims totaling $796K in drug costs for 93 beneficiaries.
What is Anuja Kriplani, MD's Medicare quality score? ▼
Anuja Kriplani, MD has a CMS MIPS Final Score of 89.6/100 (Quality: 81.9). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Anuja Kriplani, MD located? ▼
Anuja Kriplani, MD is located at 225 SUMMIT AVE, Montvale, NJ, 07645. Phone: (201) 775-7443.
What is Anuja Kriplani, MD's NPI number? ▼
Anuja Kriplani, MD's National Provider Identifier (NPI) is 1831484419, issued on 06/13/2011.
Does Anuja Kriplani, MD prescribe more brand-name or generic drugs? ▼
Anuja Kriplani, MD's prescribing is 21% brand-name and 79% generic drugs by claim count, with $759K in brand drug costs.
Does Anuja Kriplani, MD prescribe opioids? ▼
Yes, Anuja Kriplani, MD had 17 opioid claims in 2024 with an opioid prescribing rate of 4.0%.
How many Medical Oncology Physician providers are there in the US? ▼
There are 4,028 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 732 Medicare Part D claims per year.
What drugs does Anuja Kriplani, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Anuja Kriplani, MD's most frequently prescribed drugs include Levothyroxine Sodium, Dexamethasone, Ondansetron Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Anuja Kriplani, MD accept Medicare? ▼
Anuja Kriplani, MD appears in CMS Medicare data with 423 Part D claims and 93 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Anuja Kriplani, MD's credentials? ▼
Anuja Kriplani, MD's NPI is 1831484419 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.